EPM2AIP1 antibody
Quick Overview for EPM2AIP1 antibody (ABIN2720297)
Target
See all EPM2AIP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Homo sapiens EPM2A (laforin) interacting protein 1 (EPM2AIP1)
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human EPM2AIP1(NP_055620) produced in HEK293T cell.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- WB 1:2000, IHC 1:150, FLOW 1:100,
-
Comment
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Alternative Name
- EPM2AIP1
-
Background
- The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless. COMPLETENESS: complete on the 3' end.
-
Molecular Weight
- 70.2 kDa
-
Gene ID
- 9852
-
NCBI Accession
- NM_014805
-
HGNC
- 9852
Target
-